LivingGLP1
Study S001907

Real-world Canadian Retrospective Study Evaluating Longitudinal SEMAglutide Use on Cardio-Kidney-Metabolic Outcomes

ClinicalTrials.gov record

Registration

Registration
NCT07424430
Acronym
SEMA-CKM
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
3392
Start
2026-02-20
Primary completion
2026-09-28
Lead sponsor
LMC Diabetes & Endocrinology Ltd.
Conditions
Diabetes (DM); Type 2 Diabetes; Obesity (Disorder)
Interventions
DRUG:Semaglutide (SEMA)
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Change in HbA1c- 3 Years [Baseline to 3 Years]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.